Does the "Root Removal First" strategy prevent postoperative complications in the surgical removal of impacted mandibular third molars in the Pell and Gregory class C and horizontal position? - a randomized clinical trial.

Alveolar bone Extraction Impacted mandibular third molar Inferior alveolar nerve Mandibular second molar

Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
14 06 2023
Historique:
received: 09 03 2023
accepted: 28 05 2023
medline: 16 6 2023
pubmed: 15 6 2023
entrez: 14 6 2023
Statut: epublish

Résumé

To evaluate the clinical outcomes of the "Root Removal First" strategy in the surgical removal of impacted mandibular third molar (IMTM) in the class C and horizontal position. A total of 274 cases were finally included in the statistics. The positions of IMTM in the horizontal position were confirmed by cone-beam computed tomography (CBCT). Cases were randomly divided into two groups: the "Root Removal First" strategy was applied in the new method (NM) group, and the conventional "Crown Removal First" strategy was executed in the traditional method (TM) group. The clinical information and relevant data upon follow-up were recorded. The duration of the surgical removal and the incidence rates of lower lip paresthesia in the NM group were significantly lower than those in the TM group. The degree of mobility of the adjacent mandibular second molar (M2) in the NM group was significantly lower than that in the TM group at 30 days and 3 months post-operation. The distal and buccal probing depth of the M2, as well as the exposed root length of M2 in the NM group, were significantly lower than those in the TM group 3 months post-operation. The "Root Removal First" strategy can reduce the incidence rate of inferior alveolar nerve injury and periodontal complications of the M2 in the surgical removal of IMTM in class C and horizontal position with high efficiency. ChiCTR2000040063.

Identifiants

pubmed: 37316782
doi: 10.1186/s12903-023-03086-9
pii: 10.1186/s12903-023-03086-9
pmc: PMC10268342
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391

Informations de copyright

© 2023. The Author(s).

Références

Turk J Gastroenterol. 2019 Feb;30(2):171-176
pubmed: 30457557
J Clin Med. 2021 Jun 16;10(12):
pubmed: 34208701
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):63-69
pubmed: 31476533
Oral Maxillofac Surg. 2019 Dec;23(4):453-458
pubmed: 31456131
Oral Dis. 2021 May;27(4):1042-1051
pubmed: 32790913
Int J Oral Maxillofac Surg. 2002 Jun;31(3):309-17
pubmed: 12190139
Int J Oral Maxillofac Surg. 2019 Dec;48(12):1577-1583
pubmed: 31362896
Clin Oral Investig. 2021 Feb;25(2):617-625
pubmed: 32833133
J Oral Maxillofac Surg. 2011 Nov;69(11):2691-7
pubmed: 21864969
J Can Dent Assoc. 2005 Mar;71(3):185-90
pubmed: 15763037
Int J Clin Pract. 2023 Jan 3;2023:9563476
pubmed: 36694610
Quintessence Int. 2021 May 7;52(6):538-546
pubmed: 33880908
J Am Dent Assoc. 2010 Mar;141(3):271-8
pubmed: 20194382
Int J Oral Surg. 1985 Feb;14(1):29-40
pubmed: 3921477
Br J Oral Maxillofac Surg. 2005 Feb;43(1):7-12
pubmed: 15620767
Clin Oral Investig. 2007 Jun;11(2):133-42
pubmed: 17186310
Oral Maxillofac Surg Clin North Am. 2020 Nov;32(4):519-559
pubmed: 32919832
Clin Oral Investig. 2017 May;21(4):1335-1342
pubmed: 27316639
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Nov;96(5):535-9
pubmed: 14600686
Oral Maxillofac Surg Clin North Am. 2007 Feb;19(1):117-28, vii
pubmed: 18088870
J Clin Periodontol. 2002 Nov;29(11):1004-11
pubmed: 12472993
J Exp Zool B Mol Dev Evol. 2017 Jun;328(4):321-333
pubmed: 28251806
J Oral Maxillofac Surg. 2011 Jul;69(7):1858-66
pubmed: 21549479
Int J Dent. 2021 Mar 24;2021:8841297
pubmed: 33833805
J Oral Maxillofac Surg. 2019 Nov;77(11):2221.e1-2221.e14
pubmed: 31356802
J Oral Rehabil. 2018 Mar;45(3):250-257
pubmed: 29171914
Clin Oral Investig. 2019 Apr;23(4):1595-1604
pubmed: 30145660
J Maxillofac Oral Surg. 2022 Dec;21(4):1126-1139
pubmed: 36896079
SADJ. 2010 Sep;65(8):342-4, 346-8, 350-1
pubmed: 21133047

Auteurs

Bing Wang (B)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China.

Rui Sun (R)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China.
Department of Oral Surgery, School & Hospital of Stomatology, Wuhan University, Wuhan, China.

Tingting Li (T)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China.

Yuqi Sun (Y)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China.

Linwei Zheng (L)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China.

Jihong Zhao (J)

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, China. jhzhao988@whu.edu.cn.
Department of Oral Surgery, School & Hospital of Stomatology, Wuhan University, Wuhan, China. jhzhao988@whu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH